Long-Term Efficacy and Safety of First-Line Ibrutinib-Venetoclax in Older Patients with Chronic Lymphocytic Leukemia: Insights from the 67-Month GLOW Study
Posted inHematology-Oncology news Oncology

Long-Term Efficacy and Safety of First-Line Ibrutinib-Venetoclax in Older Patients with Chronic Lymphocytic Leukemia: Insights from the 67-Month GLOW Study

The GLOW phase III trial demonstrates that fixed-duration ibrutinib-venetoclax provides superior overall survival, progression-free survival, and safety compared to chlorambucil-obinutuzumab in older/comorbid CLL patients, with durable disease control and reduced need for second-line therapy.
Feasibility and Clinical Utility of Gastric Point-of-Care Ultrasound (G-POCUS) for Postoperative Gastric Content Assessment
Posted inGastroenterology news Nursing & care

Feasibility and Clinical Utility of Gastric Point-of-Care Ultrasound (G-POCUS) for Postoperative Gastric Content Assessment

This prospective pilot study demonstrates that gastric point-of-care ultrasound (G-POCUS) performed by trained nurses is a feasible, well-tolerated, and reliable method to assess gastric content in patients recovering from gastrointestinal surgery, supporting its integration into routine postoperative care.
Glucagon-Like Peptide-1 Receptor Agonists in Pregnancy: Evaluating Periconception Exposure and Perinatal Outcomes
Posted inDiabetes & Endocrinology news OB/GYN & Women's Health

Glucagon-Like Peptide-1 Receptor Agonists in Pregnancy: Evaluating Periconception Exposure and Perinatal Outcomes

GLP-1 receptor agonists are increasingly used in women of reproductive age, but their safety during periconception and pregnancy remains unclear. Current observational data show no definitive harm, yet robust evidence is lacking, emphasizing individualized counseling and further research.